ProMetic Life Sciences Inc. announced that at its 2013 annual and special meeting of shareholders, the shareholders elected Dr. Simon Best as a new board member and appointed as chairman of the board.
Liminal BioSciences Inc.
Equities
PJ2
CA53272L2021
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+41.29% | 50.93B | |
-0.38% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+12.89% | 26.02B | |
-21.93% | 18.9B | |
+7.52% | 13.21B | |
+24.59% | 12.17B | |
+30.35% | 12.16B |